Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Shuttle Pharmaceuticals Holdings, Inc. (SHPH)

Shuttle Pharmaceuticals replaces Forvis Mazars with Bush & Associates as auditor

Neutral Impact 2 of 5 other

Shuttle Pharmaceuticals Holdings dismissed Forvis Mazars, LLP as its independent registered public accounting firm and engaged Bush & Associates CPA LLC on November 2, 2026. Bush & Associates will audit the fiscal year ending December 31, 2026, and review interim financial statements through September 30, 2027. The filing states no disagreements or reportable events with the former auditor.

Key points

  • Forvis Mazars dismissal was approved by the Audit Committee and full Board, effective after the Form 10-Q for the quarter ended September 30, 2026, as previously reported October 21, 2026.
  • Bush & Associates CPA LLC was engaged on November 2, 2026, under an engagement letter dated October 19, 2026.
  • Bush & Associates will audit fiscal 2026 and review interim quarters ending March 31, June 30 and September 30, 2027.
  • The company states there were no consultations with Bush & Associates on accounting matters and no disagreements or reportable events in fiscal 2024, fiscal 2025 or the interim period through November 2, 2026.

The filing

CompanyShuttle Pharmaceuticals Holdings, Inc. (SHPH)
Form8-K, current report
Filed with the SECNov 6, 2026, 5:25 PM ET
Accession number0001493152-26-050532

Items reported: 4.01 Auditor Change

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 7:05 AM ET, from this filing only.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.